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INTRODUCTION
Acute lymphoblastic leukemia (ALL) is a malignant hematopoie-
tic neoplasia, which is rare in adults(1,2). In this condition, lymphoid 
precursors proliferate and replace normal marrow elements. Lym-
phoblasts also proliferate in other organs, most commonly in the liver, 
spleen, and lymph nodes(1). Patients with ALL frequently present with 
fever and other symptoms related to either the lack of normal marrow 
cells (anemia, neutropenia, and thrombocytopenia) or symptoms 
related to the direct infiltration of the marrow or other organs by 
leukemic cells(1). In contrast to pediatric ALL, and despite intensive 
treatment, only 20%-46% of adults with ALL are cured(1,3).
Almost any ocular structure can be affected by leukemia, either 
through direct infiltration, hemorrhage, or ischemia (due to ane mia, 
thrombocytopenia, or leukostasis) or as a consequence of oppor tu nistic 
infections(4). The fundus of patients with ALL often exhibit in traretinal 
and/or white-centered hemorrhage, tortuous dilated veins, cotton 
wool spots, vascular sheathing, and leukemic infiltrates(4,5); mean-
while, serous retinal detachment is a rare complication(4,5). Although 
fundus alterations are present in up to 90% of ALL patients over the 
course of the disease(5) and up to 50% at the time of diagnosis(6), 
these are usually asymptomatic and are rarely presenting sign of the 
disease(5). 
The purpose of our study was to describe a case of ALL presenting 
with bilateral serous macular detachment in an adult.
CASE REPORT
We describe the case of a 63-year-old female who was admitted 
to the emergency unit with bilateral, painless, and progressive loss of 
visual acuity developing over two weeks. The complete clinical his-
tory was recorded, and physical examination revealed fever (38.3°C) 
and cervical lymphadenopathy. 
Best-corrected visual acuity (BCVA) was 2/10 in the right eye and 
3/10 in the left eye. Fundus examination (Figure 1 A, B) showed bi-
lateral macular serous detachment, which was confirmed by optical 
coherence tomography (Figure 1 C, D). Central macular thickness on 
the right and left eye was 638 µm and 423 µm, respectively. Fluores-
cein angiography (Figure 1 E, F) revealed hyperfluorescent pinpoints 
in the posterior poles. The limits of the macular detachment were 
revealed in the late phase of the angiogram. 
Blood tests (Table 1) were performed and revealed anemia, neu-
tropenia with 80% blast cells in the white cell series, thrombocyto-
penia, and marginally increased C-reactive protein (CRP) levels. Based 
on these findings, the patient was referred to the Hematology De-
partment, where bone marrow examination was performed (Figure 
2), revealing increased cellularity with 97% blast cells. The patient 
was diagnosed with ALL type B (CD10+) using immunophenotyping.
Intensive systemic chemotherapy (rituximab-hyperCVAD (fractio-
nated cyclophosphamide, vincristine, doxorubicin, and dexame tha-
sone) regimen plus intrathecal therapy (methotrexate/cytara bine) was 
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ABSTRACT
Acute lymphoblastic leukemia is a malignant hematopoietic neoplasia, which is 
rare in adults. Although ocular fundus alterations may be commonly observed 
in the course of the disease, such alterations are rarely the presenting signs of 
the disease. Here we describe the case of a patient with painless and progressive 
loss of visual acuity (right eye, 2/10; left eye, 3/10) developing over two weeks, 
accompanied by fever and cervical lymphadenopathy. Fundus examination showed 
bilateral macular serous detachment, which was confirmed by optical coherence 
tomography. Fluorescein angiography revealed hyperfluorescent pinpoints in the 
posterior poles. The limits of the macular detachment were revealed in the late 
phase of the angiogram. The results of blood count analysis triggered a thorough, 
systematic patient examination. The diagnosis of acute lymphoblastic leukemia B 
(CD10+) was established, and intensive systemic chemotherapy was immediately 
initiated. One year after the diagnosis, the patient remains in complete remission 
without any ophthalmologic alterations.
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RESUMO
A leucemia linfoblástica aguda é uma neoplasia maligna das células hematopoié-
ticas, incomum em adultos. Apesar da maioria dos casos apresentar alterações no 
fundo ocular no decurso da doença, estas são raramente forma de apresentação da 
mesma. Descreve-se o caso de uma doente com diminuição progressiva e indolor da 
acuidade visual (OD 2/10 e OE 3/10), que apresentava concomitantemente febre e 
adenopatias cervicais, com duas semanas de evolução. À oftalmoscopia apresentava 
descolamento seroso macular bilateral, confirmado por tomografia de coerência 
ótica. A angiografia fluoresceínica revelou pequenas lesões hiperfluorescentes tipo 
pinpoints no polo posterior. Nos tempos médios e tardios do exame adivinham-se 
os limites da bolsa do descolamento do neuroepitélio. As alterações encontradas no 
hemograma suscitaram um estudo sistêmico extenso. O diagnóstico de leucemia 
linfoblástica aguda B (CD10+) foi efetuado, iniciando-se, de imediato, quimioterapia 
sistêmica intensiva. Um ano após o diagnóstico a doente continua em remissão e sem 
alterações oftalmológicas de novo.
Descritores: Leucemia linfoblástica aguda; Descolamento seroso macular; Acuidade 
visual; Tomografia de coerência ótica; Angiografia fluoresceínica
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Figure 2. Giemsa-stained smear of bone marrow aspirate. A lymphoblast is indi-
cated by the arrow.
Figure 3. Findings after the second cycle of chemotherapy: A) and B) Fundus photographs 
of the right and left eye, respectively, with no significant alterations. C) and D) Optical 
coherence tomography (horizontal sections) of the right and left eye, respectively, at the 











Figure 1. Findings at presentation: A) and B) Fundus photographs of the right and 
left eye, respectively, showing shallow serous macular detachment. C) and D) Optical 
coherence tomography (horizontal sections) of the right and left eye, respectively, 
at the level of the fovea, showing neurosensory detachment, with central macular 
thickness of 638 µm and 423 µm in the right and left eye, respectively. E) and F) Fluo-
rescein angiogram of the right and left eye, respectively, showing hyperfluorescent 
pinpoints in the posterior poles. The limits of the macular detachment were revealed 
in the late phase of the angiogram.
Table 1. Blood tests performed upon admission 
Erythrocytes↓ 2.42 x 1012/L 
Hemoglobin↓ 8.2 x 10g/L 
Hematocrit↓ 24.7% 
Mean cell volume↑ 102.1 fL
Mean cell hemoglobin↑ 33.9 pg
Red cell distribution width↑ 17.5% 
Leucocytes↑↑ 25.40 x 109/L 
Neutrophils↓ 0.76 x 109/L 
Eosinophils 0.00 x 109/L 
Basophils 0.00 x 109/L 
Lymphocytes 4.32 x 109/L 
Monocytes↓ 0.00 x 109/L 
Blasts↑↑ 80% 
Platelets↓ 66 x 109/L 
Platelet distribution width↑ 18.8% 
Erythrocyte sedimentation rate 12 mm/h 
C-reactive protein↑ 14.4 mg/L 
Liver and kidney function tests, autoimmune 
test, infection serological tests
No alterations
scheduled and initiated immediately. After the first che mo therapy 
cycle, complete remission was achieved, and a BCVA of 10/10 was 
obtained in both eyes with reattachment of the macula (Figure 3) after 
the second cycle. One year after the diagnosis, the patient remains in 
complete remission without any ophthalmologic alterations.
DISCUSSION
Ophthalmological involvement in leukemia, which is more common 
in acute than in chronic disease(4,6), is not unusual but is rarely a pre-
senting sign of the disease(5). Although leukemic retinopathy (intra-
retinal hemorrhages, white-centered hemorrhages and cotton-wool 
spots) is the most frequent fundus finding and retinal infiltrates are 
easily seen, choroidal infiltration is rarely observed clinically (5). Ho-
wever, the choroid is affected in 30% to 93% of the cases as demons-
trated by histopathological studies(2,4,7), and decreased thickness after 
chemotherapy has been reported by Bajenova et al.(7). 
When the choroidal infiltration is severe, it leads to serous retinal 
detachment, which is reported to be shallow in the posterior pole, 
more common in adults, and bilateral(5). 
Other diseases may present with serous macular detachment, such 
as central serous chorioretinopathy, age-related macular degenera-
tion, Harada´s syndrome, melanoma, hemangioma, metastases, 
sympathetic ophthalmitis, posterior scleritis, and uveal effusion syn-
drome. In our case, the existence of fever and cervical lymphadeno-
pathy, and the absence of other relevant ophthalmologic or systemic 
findings, as revealed by clinical history and physical examination, 
led to the suspicion of hematologic neoplasia, with the angiogram 
results correlating with the findings described in the scientific lite-
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rature(5). Moreover, the resolution of the macular detachment with 
systemic chemotherapy was in favor of our theory that serous macular 
detach ment was due to leukemic choroidal infi ltration. 
The physiopathological mechanism postulated(5) is that choroidal 
infi ltration leads to a decreased blood fl ow in the choriocapillaris, re-
sulting in ischemia and the disruption of the intercellular tight junctions 
or the necrosis of the retinal pigment epithelium, as evidenced by 
the multifocal hyperfl uorescent pinpoints in the early phases of fl uo-
res cein angiography. This decompensated posterior blood-retinal 
barrier leads to exudation as evidenced by the diff use subretinal 
accumulation of fl uorescein in the late phase of the angiogram.
This rare case illustrates the importance of a systematic examina-
tion in managing a case of bilateral macular serous detachment, with 
no other signs suggestive of local injury. This is particularly important 
when early treatment is imperative and is critical to patient survival.
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